Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nandurkar

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Stroke|April 2, 2021
Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19Maithili Sashindranath, Harshal H Nandurkar
IUBMB Life|May 23, 2002
The myotubularin family: novel phosphoinositide regulatorsHarshal H Nandurkar, Richard Huysmans
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 1993
The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150E J Favaloro, T Browning, H Nandurkar
Stem Cells (Dayton, Ohio)|September 30, 2000
The role of IL-II in hematopoiesis as revealed by a targeted mutation of its receptorH H Nandurkar, L Robb, C G Begley
Purinergic Signalling|August 10, 2022
CD39 in the development and progression of pulmonary arterial hypertensionAbbey Willcox, Natasha Ting Lee, Harshal H Nandurkar, et al.
Journal of Thrombosis and Thrombolysis|April 18, 2016
Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked eventsH Y Lim, C Ng, G Donnan, et al.
Internal Medicine Journal|July 5, 2012
Out of sight, out of mind: an audit of inferior vena cava filter insertion and clinical follow up in an Australian institution and literature reviewX L Tan, C Tam, R Mckellar, et al.
Internal Medicine Journal|July 4, 2014
Prevalence and predictors of fatigue in haemo-oncological patientsR Zordan, V Manitta, H Nandurkar, et al.
Internal Medicine Journal|May 13, 2014
Low-molecular-weight heparin biosimilars: potential implications for clinical practice. Australian Low-Molecular-Weight Heparin Biosimilar Working Group (ALBW)H Nandurkar, B Chong, H Salem, et al.
Blood Advances|May 17, 2022
The potential role of protease systems in hemophilic arthropathyWayne W S Hauw, Joanne S J Chia, Harshal H Nandurkar, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Stroke|April 2, 2021
Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19Maithili Sashindranath, Harshal H Nandurkar
IUBMB Life|May 23, 2002
The myotubularin family: novel phosphoinositide regulatorsHarshal H Nandurkar, Richard Huysmans
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 29, 1993
The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150E J Favaloro, T Browning, H Nandurkar
Stem Cells (Dayton, Ohio)|September 30, 2000
The role of IL-II in hematopoiesis as revealed by a targeted mutation of its receptorH H Nandurkar, L Robb, C G Begley
Purinergic Signalling|August 10, 2022
CD39 in the development and progression of pulmonary arterial hypertensionAbbey Willcox, Natasha Ting Lee, Harshal H Nandurkar, et al.
Journal of Thrombosis and Thrombolysis|April 18, 2016
Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked eventsH Y Lim, C Ng, G Donnan, et al.
Internal Medicine Journal|July 5, 2012
Out of sight, out of mind: an audit of inferior vena cava filter insertion and clinical follow up in an Australian institution and literature reviewX L Tan, C Tam, R Mckellar, et al.
Internal Medicine Journal|July 4, 2014
Prevalence and predictors of fatigue in haemo-oncological patientsR Zordan, V Manitta, H Nandurkar, et al.
Internal Medicine Journal|May 13, 2014
Low-molecular-weight heparin biosimilars: potential implications for clinical practice. Australian Low-Molecular-Weight Heparin Biosimilar Working Group (ALBW)H Nandurkar, B Chong, H Salem, et al.
Blood Advances|May 17, 2022
The potential role of protease systems in hemophilic arthropathyWayne W S Hauw, Joanne S J Chia, Harshal H Nandurkar, et al.
Pageof 6